Log in to save to my catalogue

Furosemide with adjunctive acetazolamide vs furosemide only in critically ill patients: A pilot two-...

Furosemide with adjunctive acetazolamide vs furosemide only in critically ill patients: A pilot two-...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3146947744

Furosemide with adjunctive acetazolamide vs furosemide only in critically ill patients: A pilot two-center randomized controlled trial

About this item

Full title

Furosemide with adjunctive acetazolamide vs furosemide only in critically ill patients: A pilot two-center randomized controlled trial

Publisher

United States: Elsevier Inc

Journal title

Journal of critical care, 2025-04, Vol.86, p.155002, Article 155002

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

Furosemide is the most commonly used diuretic in intensive care units (ICU). We aimed to evaluate the physiological effects of adjunctive acetazolamide with furosemide on diuresis and the prevention of potential furosemide-induced metabolic alkalosis.
We performed a two-center, pilot, open-label, randomized trial. Where the treating physicians p...

Alternative Titles

Full title

Furosemide with adjunctive acetazolamide vs furosemide only in critically ill patients: A pilot two-center randomized controlled trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3146947744

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3146947744

Other Identifiers

ISSN

0883-9441,1557-8615

E-ISSN

1557-8615

DOI

10.1016/j.jcrc.2024.155002

How to access this item